Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research

Stock Information for Rapid Dose Therapeutics Corp - Ordinary Shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Rapid Dose Therapeutics Corp - Ordinary Shares

Rapid Dose Announces Proposed Debt Settlement
Rapid Dose Therapeutics to Showcase Xylistrip, a Dental Product, at Key Tradeshows Across Canada
Rapid Dose Therapeutics Corp. Announces Payment in Shares for Quarterly Interest on Secured Debt and Update on Shares for Debt Settlement with Creditors
Rapid Dose Therapeutics Corp Announces Proposed Equity Private Placement Financing
Rapid Dose Therapeutics Advances Collaboration with Global Leader for Market-Ready QuickStrip(R) Nicotine in 2025
Rapid Dose Provides Update on Share Issuance in Debt Settlement with Creditors and Proposed Private Placement
Rapid Dose Completes Issuance of Shares as Payment of Directors' Fees
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.